32,628 Shares of Cencora, Inc. $COR Bought by Pensioenfonds Rail & OV

Pensioenfonds Rail & OV bought a new position in shares of Cencora, Inc. (NYSE:COR) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 32,628 shares of the company’s stock, valued at approximately $9,797,000. Cencora accounts for about 2.6% of Pensioenfonds Rail & OV’s holdings, making the stock its 9th largest holding.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. BlackRock Inc. bought a new position in Cencora during the second quarter worth about $5,154,136,000. Bank of America Corp DE boosted its holdings in Cencora by 6.9% in the 1st quarter. Bank of America Corp DE now owns 4,138,388 shares of the company’s stock valued at $1,300,033,000 after purchasing an additional 267,318 shares during the period. Amundi boosted its holdings in Cencora by 43.5% in the 2nd quarter. Amundi now owns 2,229,326 shares of the company’s stock valued at $630,855,000 after purchasing an additional 676,066 shares during the period. Carmignac Gestion grew its position in shares of Cencora by 58.7% during the 2nd quarter. Carmignac Gestion now owns 1,747,363 shares of the company’s stock worth $494,463,000 after purchasing an additional 646,112 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of Cencora during the 2nd quarter worth approximately $483,772,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Transactions at Cencora

In other Cencora news, EVP Elizabeth Campbell sold 11,300 shares of Cencora stock in a transaction on Monday, August 24th. The shares were sold at an average price of $324.12, for a total transaction of $3,662,556.00. Following the transaction, the executive vice president directly owned 19,455 shares of the company’s stock, valued at $6,305,754.60. The trade was a 36.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Bank of America lifted their price target on shares of Cencora from $285.00 to $310.00 in a research report on Tuesday, July 21st. Wells Fargo & Company increased their price target on Cencora from $331.00 to $395.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 11th. Weiss Ratings upgraded Cencora from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, October 6th. JPMorgan Chase & Co. raised their price objective on Cencora from $390.00 to $413.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 10th. Finally, Robert W. Baird lifted their price objective on Cencora from $373.00 to $375.00 and gave the company an “outperform” rating in a report on Thursday, October 22nd. Twelve research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $368.14.

Cencora Trading Up 2.8%

NYSE COR traded up $9.74 on Friday, hitting $359.12. The company’s stock had a trading volume of 1,393,211 shares, compared to its average volume of 1,421,795. The company has a quick ratio of 0.59, a current ratio of 0.94 and a debt-to-equity ratio of 3.01. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54. The company’s 50-day moving average is $327.12 and its 200 day moving average is $317.20. The firm has a market cap of $68.53 billion, a PE ratio of 20.04, a PEG ratio of 1.81 and a beta of 0.58.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $4.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.58 by $0.08. The company had revenue of $88.35 billion during the quarter, compared to the consensus estimate of $87.95 billion. Cencora had a return on equity of 110.72% and a net margin of 1.03%. The firm’s revenue was up 5.5% compared to the same quarter last year. During the same period last year, the company earned $3.84 earnings per share. As a group, analysts predict that Cencora, Inc. will post 19.58 earnings per share for the current fiscal year.

Cencora Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, November 13th. This is a positive change from Cencora’s previous quarterly dividend of $0.60. This represents a $2.64 annualized dividend and a dividend yield of 0.7%. Cencora’s payout ratio is presently 13.39%.

About Cencora

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.